Immunome has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $230 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Immunome is raising $230,000,000.00 in new funding. About Immunome: Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies. Our portfolio…
